Orally bioavailable beta 3-adrenergic receptor agonists as potential therapeutic agents for obesity and type-II diabetes

Prog Med Chem. 2003:41:167-94. doi: 10.1016/s0079-6468(02)41005-3.
No abstract available

Publication types

  • Review

MeSH terms

  • Administration, Oral
  • Adrenergic beta-3 Receptor Agonists*
  • Adrenergic beta-Agonists / therapeutic use*
  • Animals
  • Anti-Obesity Agents / therapeutic use*
  • Biological Availability
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Humans
  • Hypoglycemic Agents / therapeutic use*
  • Obesity / drug therapy
  • Structure-Activity Relationship

Substances

  • Adrenergic beta-3 Receptor Agonists
  • Adrenergic beta-Agonists
  • Anti-Obesity Agents
  • Hypoglycemic Agents